Efcure®
Brand Name: Efcure® 600
Manufacturer: Emcure Pharmaceuticals
Composition: Efavirenz Tablets IP (600 mg)
Product Description
Medical Info
Efcure® 600, manufactured by Emcure, is a vital prescription antiretroviral medication containing 600 mg of Efavirenz per tablet. Classified as a non-nucleoside reverse transcriptase inhibitor (NNRTI), it works by directly binding to the HIV-1 reverse transcriptase enzyme. This action blocks RNA-dependent and DNA-dependent DNA polymerase activities, effectively halting viral replication. Efcure® 600 is indicated for the clinical treatment of HIV-1 infection in adults and pediatric patients, always administered in combination with other antiretroviral therapeutic agents. Packaged as a 30-tablet supply, this targeted oral therapy must strictly be managed by a certified infectious disease specialist.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
